Comparative efficacy and safety of selective serotonin reuptake inhibitors in the short- and medium-term treatment of major depressive disorders

References

• Bengtsson B-O. On the hypersensitive syndrome induced by the selective serotonin reuptake inhibiting antidepressant zimelidine. A clinical and experimental study. Linkoping University Medical Dissertations. 1992; No 360
   Google Scholar
• Feighner I. P., Boyer W. F. Selective serotonin reuptake inhibitors. Perspectives in psychiatry. Vol 1. John Wiley Ltd., Chichester 1991
   Google Scholar
• Montgomery S. A., Montgomery D. B. Prophylactic treatment in recurrent unipolar depression. Long-term treatment of depression. Perspectives in psychiatry. Vol 3, S. Montgomery, F. Rouillon. John Wiley and Sons, Chichester 1992; 53–79
   Google Scholar
• Stark P., Hardison C. A review of multicenter controlled studies of fluoxetine vs imipramine and placebo in outpatients with major depressive disorder. J Clin Psychiatry 1985; 46: 3, 53–8
   Google Scholar
• Dunner D. L., Dubar G. C. Optimal dose regimen for paroxetine. J Clin Psychiatry 1992; 53 Suppl 2: 21–6
   Google Scholar
• Montgomery S. A., Pedersen V., Tanghoj P., Rasmussen C. The optimal dosing regimen for citalo-pram—a meta-analysis of nine placebo-controlled studies. Int Clin Psychopharmacol 1994; 9(Suppl 1)35–40
   PubMed Web of Science ®Google Scholar
• Grimsley S. R., Jann M. W. Paroxetine sertraline and fluvoxamine: new selective serotonin reuptake inhibitors. Clin Pharmacol 1992; 11: 930–57
   PubMedGoogle Scholar
• Aguglia E., Casacchia M., Casano G. B., Faravelli C. Double-blind study of the efficacy and safety of sertraline versus fluoxetine in major depression. Int Clin Psychopharmacol 1993; 8: 197–202
   PubMed Web of Science ®Google Scholar
• Schöne W., Ludwig M. A double-blind study of paroxetine compared with fluoxetine in geriatric patients with major depression. J Clin Psychopharmacol 1993; 13(Suppl 2)34S–39S
   Google Scholar
• Tignol J. A double-blind, randomized fluoxetine-controlled, multicenter study of paroxetine in the treatment of depression. J Clin Psychopharmacol 1993; 13(Suppl 2)18S–22S
   Google Scholar
• de Wilde J., Spiers R., Mertens C., Bartholome F., Schott E., Leyman S. A double-blind, comparative, multicentre study comparing paroxetine with fluoxetine in depressed patients. Acta Psychiatr Scand 1993; 87: 141–5
   PubMedGoogle Scholar
• Geretsegger C., Bohmer F., Ludwig M. Paroxetine in the elderly depressed patient: randomized comparison with fluoxetine of efficacy cognitive and behavioural effects. Int Clin Psychopharmacol 1994; 9: 25–9
   PubMed Web of Science ®Google Scholar
• Timmerman L., Haffmans PMJ, Hoogduin CAL. Efficacy and tolerability of citalopram in comparison with fluvoxamine in depressed outpatients. J Clin Psychopharmacol, In press.
   Google Scholar
• Ansseau M. A double-blind comparison of paroxetine and fluvoxamine in major depression. Eur Neuropsychopharmacol 1993; 3: 232
   Google Scholar
• Wålinder J., Feighner J. P. Novel selective serotonin reuptake inhibitions. I. J Clin Psychiatry 1992; 53: 107–12
   Google Scholar
• Brown W. A., Harrison W. Are patients who are intolerant to one SSRI intolerant to another. Psychopharmacol Bull 1992; 28: 253–6
   PubMed Web of Science ®Google Scholar
• Goodwin F. K., Jamison K. R. Manic-depressive illness. Oxford University Press, New York 1990
   Google Scholar
• Bjerkenstedt L., Edman G., Flyckt L., Hagenfelt L., Sedvall G., Wiesel F. A. Clinical and biochemical effects of citalopram a selective 5-HT reuptake inhibitor—a dose response study in depressed patients. Psychopharmacology 1985; 887: 253–9
   Google Scholar
• Stembach H. The serotonin syndrome. Am J Psychiatry 1991; 148: 705–13
   Google Scholar
• Edwards J. G., Goldie A., Papayanni-Papasthasis S., Punter J., Sedgwick E. M. The effect of paroxetine on the electroencephalogram, electrocardiogram and blood pressure. Acta Psychiatr Scand 1989; 80(Suppl 350)124
   Google Scholar
• Rasmussen JGC, Johnson A. M. Incidence of seizures during treatment with antidepressants, including the serotonin re-uptake inhibitor paroxetine. Poster presented at the 5th World Congress of Psychiatry, Florence, June 9–14 1991
   Google Scholar
• Riddle M. A., Brown N., Dzubinsld D., Jetmalani A. N., Law Y., Woolston J. L. Fluoxetine overdose in an adolescent. J Am Acad Child Adolesc Psychiatry 1989; 28: 587–8
   PubMed Web of Science ®Google Scholar
• Ware M. R., Stewart R. B. Seizures associated with fluoxetine therapy. Drug Intell Clin Pharm 1989; 23: 428
   Google Scholar
• Weber J. J. Seizures activity associated with fluoxetine therapy. Clin Pharmacol 1989; 8: 296–8
   Google Scholar
• Andersen G., Vestergaard K., Riis Jens O. Citalopram for post-stroke pathological crying. Lancet 1993; 342: 837–9
   PubMed Web of Science ®Google Scholar
• Andersen G., Vestergaard K., Lauritzen L. Effective treatment of poststroke depression with the selective serotonin reuptake inhibitor citalopram. Stroke 1994; 25: 1099–104
   PubMed Web of Science ®Google Scholar
• Nyth A. L., Gottfries C. G. The clinical efficacy of citalopram in treatment of emotional disturbances in dementia disorders. A Nordic multicentre study. Br J Psychiatry 1990; 157: 894–901
   PubMed Web of Science ®Google Scholar
• Rasmussen JGC, Manniche P. Incidence of mania during treatment with antidepressants, with particular reference to the selective serotonin re-uptake inhibitor paroxetine. Poster presented at the 5th World Congress of Psychiatry, Florence, June 9–14 1991
   Google Scholar
• Mårtensson B., Åberg-Wistedt A. Selektiva hämmare av serotoninupptag. Ny grupp antide-pressiva medel ökar i användning. Lakartidningen 1994; 38: 3371–9
   Google Scholar
• Molcho A., Stanley M. Antidepressants and suicide risk: issues of chemical and behavioural toxicity. J Clin Psychopharmacol 1992; 12: 13–8
   Google Scholar
• Leonard B. E. The comparative pharmacology of new antidepressants. J Clin Psychiatry 1993; 54: 3–15
   Google Scholar
• Eriksson T., Carlsson A., Eriksson T. E., Walinder J. Altered night plasma concentrations of tryptophan and tyrosine in mental depression. J Neural Transmission, In press.
   Google Scholar